1. Home
  2. NGVT vs HRMY Comparison

NGVT vs HRMY Comparison

Compare NGVT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • HRMY
  • Stock Information
  • Founded
  • NGVT 1964
  • HRMY 2017
  • Country
  • NGVT United States
  • HRMY United States
  • Employees
  • NGVT N/A
  • HRMY N/A
  • Industry
  • NGVT Major Chemicals
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • HRMY Health Care
  • Exchange
  • NGVT Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • NGVT 2.1B
  • HRMY 2.1B
  • IPO Year
  • NGVT N/A
  • HRMY 2020
  • Fundamental
  • Price
  • NGVT $58.13
  • HRMY $32.39
  • Analyst Decision
  • NGVT Buy
  • HRMY Strong Buy
  • Analyst Count
  • NGVT 2
  • HRMY 9
  • Target Price
  • NGVT $58.00
  • HRMY $55.33
  • AVG Volume (30 Days)
  • NGVT 266.6K
  • HRMY 651.3K
  • Earning Date
  • NGVT 10-28-2025
  • HRMY 10-28-2025
  • Dividend Yield
  • NGVT N/A
  • HRMY N/A
  • EPS Growth
  • NGVT N/A
  • HRMY 58.41
  • EPS
  • NGVT N/A
  • HRMY 3.10
  • Revenue
  • NGVT $1,324,800,000.00
  • HRMY $772,527,000.00
  • Revenue This Year
  • NGVT N/A
  • HRMY $20.09
  • Revenue Next Year
  • NGVT $5.18
  • HRMY $16.74
  • P/E Ratio
  • NGVT N/A
  • HRMY $10.44
  • Revenue Growth
  • NGVT N/A
  • HRMY 17.74
  • 52 Week Low
  • NGVT $28.49
  • HRMY $26.47
  • 52 Week High
  • NGVT $60.77
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 59.21
  • HRMY 30.32
  • Support Level
  • NGVT $56.99
  • HRMY $32.87
  • Resistance Level
  • NGVT $60.77
  • HRMY $37.05
  • Average True Range (ATR)
  • NGVT 1.48
  • HRMY 1.15
  • MACD
  • NGVT -0.39
  • HRMY -0.60
  • Stochastic Oscillator
  • NGVT 42.73
  • HRMY 1.59

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: